Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6166382

CCOC(=O)C(Cc1ccnc(/C=N\N)c1)NC(=O)c1ccc(-c2ccccc2C#N)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.42
CTSG P08311 3/20 0.41
CMA1 P23946 2/20 0.40
CTSD P07339 1/20 0.40
BACE1 P56817 1/20 0.40
BACE2 Q9Y5Z0 1/20 0.40
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 1/20 0.39
CYP26A1 O43174 1/20 0.38
CTSS P25774 5/20 0.38
CTSB P07858 4/20 0.38
CTSK P43235 4/20 0.38
CTSL P07711 3/20 0.37
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6166385 1.00 PTPN1 (0.42) PTPN1CTSGCMA1CTSDBACE1
Trifluoroacetic Acid SCHEMBL7106866 0.94 PTPN1 (0.42) PTPN1CTSGCMA1CTSDBACE1
Trifluoroacetic Acid SCHEMBL7106872 0.94 PTPN1 (0.42) PTPN1CTSGCMA1CTSDBACE1
Trifluoroacetic Acid SCHEMBL6166384 0.86 PTPN1 (0.42) PTPN1CTSGCMA1CTSDBACE1
Trifluoroacetic Acid SCHEMBL6164344 0.82 CTSB (0.43) PTPN1CTSGCMA1CTSDBACE1
Trifluoroacetic Acid SCHEMBL6164351 0.82 CTSB (0.43) PTPN1CTSGCMA1CTSDBACE1
Trifluoroacetic Acid SCHEMBL7106869 0.80 F10 (0.44) PTPN1GAARAB9ACTSSCTSB
Trifluoroacetic Acid SCHEMBL6167616 0.75 F10 (0.48) GAARAB9A
Trifluoroacetic Acid SCHEMBL6167607 0.75 F10 (0.48) GAARAB9A
Trifluoroacetic Acid SCHEMBL7108467 0.75 PTPN1 (0.41) PTPN1CTSDBACE1BACE2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US claimed
EP-1254136-A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF LG CHEM INVESTMENT LTD (KR) 2005-06-01 EP disclosed
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed
EP-1254136-A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF LG Chem Investment, Ltd. (KR) 2002-11-06 EP disclosed
WO-2001055146-A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF LG CHEM INVESTMENT LTD. (KR) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI PTPN1 1142/4885CTSG 814/4885CMA1 378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.